Clinical trial
A Clinical Trail of KJ015 in Patients With HER2-Expressing Solid Tumors
NCT07036185
Study timeline
Study start (estimated)2025-06-24Date precision: day
Registry last updated2025-06-25
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Gastric/Gastroesophageal Junction Cancerunresolved
Breast Cancerunresolved
Colorectal Cancerunresolved
Non-small Cell Lung Cancer (NSCLC)unresolved
Bile Duct Cancerunresolved
Head and Neck Squamous Cell Carcinomaunresolved
Interventions
Sponsors & collaborators
Shanghai Bao Pharmaceuticals Co., Ltd.lead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT07036185 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.